Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Kuehne+Nagel announced the opening of a new, temperature-controlled fulfilment centre for its partner Medtronic. The global ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

Medtronic sells products in many end markets in these segments. It is usually the market leader or number two in each end market. Total revenue was more than $32.36 billion in fiscal year 2023 and ...

Medtronic delivered a strong first-quarter earnings report. The company benefits from continued market adoption of several new product launches over the past year. The stock looks attractive ...

A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

There will continue to be a dire need for products that help simplify the lives of these patients. Medtronic is one of the more prominent companies in this niche, which could provide it with a ...

Investors signalled that they were pleased with Medtronic plc's (NYSE:MDT) most recent earnings report. Looking deeper at the numbers, we found several encouraging factors beyond the headline ...

Carillon Eagle Growth & Income Fund highlighted stocks like Medtronic plc (NYSE:MDT), in the second quarter 2024 investor letter. Medtronic plc (NYSE:MDT) develops, manufactures, and distributes ...